Congenital Cataracts - RNIB - See differently

Nepafenac is a non steroid prodrug used to treat inflammation in patients recovering from cataract surgery. Approved by FDA, Nepafenac is hydrolyzed by intraocular tissues to active form, Amfenac which is a potent COX-2 inhibitor. In addition to limited hydrolysis in the cornea, significant bioactivation also occurs in the iris or ciliary body ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download